FREE TRACKED SHIPPING OVER £50•SAME-DAY DISPATCHMON–FRI BEFORE12:00 UK

Research area

Tissue-repair research peptides

BPC-157, TB-500, KPV and fixed-ratio blends — the core peptides used in laboratory research on cell migration, angiogenesis and cytoprotective signalling.

7 productsHPLC-tested batchesSame-day dispatch before 12:00 UKFree tracked UK & EU shipping over £50
BPC-157 — mypeptides vial
Best seller
Peptides
BPC-157
5 mg · ≥99%
£24.99£29.99-17%
TB-500 — mypeptides vial
Peptides
TB-500
5 mg · ≥99%
£39.99£49.99-20%
BPC-157 + TB-500 — mypeptides vial
Best seller
Peptides
BPC-157 + TB-500
10 mg · ≥99%
£44.99
BPC-157 + TB-500 + MGF — mypeptides vial
Peptides
BPC-157 + TB-500 + MGF
18.5 mg · ≥99%
£89.99
KPV — mypeptides vial
Peptides
KPV
5 mg · ≥99%
£29.99£49.99-40%
BPC-157 Nasal Spray — mypeptides vial
Nasal Sprays
BPC-157 Nasal Spray
10 mg · ≥99%
£39.99£49.99-20%
BPC-157 + TB-500 Nasal Spray — mypeptides vial
Nasal Sprays
BPC-157 + TB-500 Nasal Spray
5 mg · ≥99%
£39.99£49.99-20%

BPC-157 and TB-500

BPC-157 is a 15-amino-acid peptide derived from a fragment of the gastric protein BPC and has been characterised in soft-tissue, vascular and cytoprotective-signalling studies for more than two decades. TB-500 is a synthetic peptide based on the actin-binding region of thymosin β4 and is studied for cell-migration and cytoskeletal-remodelling pathways.

Because they act on different pathways, the two are often run side by side in comparative repair models.

Blends and KPV

The BPC-157 + TB-500 blend fixes a 5 mg + 5 mg ratio in one vial so the ratio stays identical across samples; the triple blend adds the IGF-1 splice-variant peptide MGF. KPV, the C-terminal Lys-Pro-Val tripeptide of α-MSH, is studied in inflammatory-signalling cell models.

Orders placed before 12:00 UK time (Mon–Fri) are dispatched the same working day by tracked delivery, free on UK & EU orders over £50.

At a glance

BPC-157Angiogenesis & cytoprotective signalling5 mg & 10 mg vials · spray
TB-500Actin regulation & cell migration5 mg vial
BPC-157 + TB-500Combined repair models10 mg vial · spray
KPVInflammatory-signalling models5 mg vial

Frequently asked questions

What is the difference between BPC-157 and TB-500?

BPC-157 is a gastric-protein-derived pentadecapeptide studied mainly in angiogenesis and cytoprotective-signalling models; TB-500 is a thymosin β4-derived peptide studied for actin regulation and cell migration. They target different pathways, which is why they are often compared or combined.

Why choose a blend instead of two vials?

A blend fixes the ratio in a single vial, which removes a mixing step and keeps the ratio identical between samples. Separate vials give you control over the ratio.

How should these peptides be stored?

Lyophilised vials at −20 °C, protected from light; reconstitute with bacteriostatic or sterile water immediately before use. Sprays at 2–8 °C.

Are tissue-repair peptides for human use?

No. Everything in this range is supplied strictly as laboratory research material for in-vitro use. It is not a medicine, food, supplement or cosmetic and is not for human or veterinary use.

Research notice: every product in this range is supplied strictly as laboratory research material for in-vitro use. Not for human or veterinary use, and not a medicine, food, supplement or cosmetic.